1X10^6 human PBMCs were surface stained with 0.2 ug Anti-Human CD7 (65203-1-Ig, Clone:4H9) or Mouse IgG2a Isotype Control, and CoraLite®594-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L) at dilution 1:500, then CL405 Anti-Human CD4. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 0.2 ug Anti-Human CD7 (65203-1-Ig, Clone:4H9) or Mouse IgG2a Isotype Control, and CoraLite®594-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L) at dilution 1:500. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with APC Anti-Human CD4 and 5 ul Atlantic Blue™ Anti-Human CD7 (AB-65203, Clone:4H9) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Atlantic Blue™ Anti-Human CD7 (AB-65203, Clone:4H9) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with APC Anti-Human CD4 and 5 ul Cardinal Red™ Anti-Human CD7 (CR-65203, Clone:4H9) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Cardinal Red™ Anti-Human CD7 (CR-65203, Clone:4H9) (red) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite®405 Anti-Human CD7 (CL405-65203, Clone:4H9) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite®405 Anti-Human CD7 (CL405-65203, Clone:4H9) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with APC Anti-Human CD4 and 5 ul CoraLite® Plus 488 Anti-Human CD7 (CL488-65203, Clone:4H9) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 488 Anti-Human CD7 (CL488-65203, Clone:4H9) (red) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with APC Anti-Human CD4 and 5 ul CoraLite® Plus 555 Anti-Human CD7 (CL555-65203, Clone:4H9) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with Atlantic Blue Anti-Human CD4 and 5 ul CoraLite® Plus 647 Anti-Human CD7 (CL647-65203, Clone: 4H9), or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with APC Anti-Human CD4 and 5 ul CoraLite®750 Anti-Human CD7 (CL750-65203, Clone:4H9) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite®750 Anti-Human CD7 (CL750-65203, Clone:4H9) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---